IVC Filter Lawsuit Results in $3.6M Jury Award Against Bard in First Bellwether Trial

A federal jury in Arizona has ordered C.R. Bard to pay nearly $4 million in the first IVC filter lawsuit to go to trial, which was designed to serve as a “bellwether” and help gauge how juries are likely to respond to certain evidence and testimony that may be repeated in thousands of other cases. 

There are currently more than 3,500 Bard IVC Filter cases pending in the federal court system, each involving similar allegations that the small blood clot filters fractured or migrated out of position, causing a variety of serious and potentially life-threatening injuries.

A lawsuit filed by Sherr-Una Booker was selected as the first in a series of early test trial dates, alleging that a Bard G2 Vena Cava filter fractured inside her body.

Following a multi-week trial, the jury awarded $2 million in compensatory damages, with 80% of the award assessed against C.R. Bard. The company was then ordered to pay an additional $2 million in punitive damages, resulting in a combined verdict of $3.6 million.

Another Bard IVC filter bellwether trial is set to begin on May 15, involving similar claims raised in a lawsuit filed by Doris and Alfred Jones.

Given similar questions of fact and law presented in claims filed in U.S. District Courts nationwide, the litigation is centralized before U.S. District Judge David G. Campbell in the District of Arizona, for coordinated discovery and a series of early trial dates.

Ahead of the Jones trial, a court order (PDF) issued March 30, indicating that the court will hold a hearing on April 13 to discuss issues brought up during the Booker trial, which may affect the Jones case. Each party has been ordered to file a five page memorandum by April 10 outlining which issues should be considered.

While the outcome of this trial and other bellwether cases will not be binding of remaining claims in the litigation, they will be closely watched by parties involved, and may influence eventual negotiations to reach IVC filter settlements, which would avoid the need for thousands of separate trials to be held nationwide.

In addition to cases against Bard, another 3,750 Cook IVC filter lawsuits are centralized as part of a separate MDL, involving similar allegations of design defects associated with that competing product.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.
Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.
Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation.